Pixantrone (Novuspharma)

IDrugs. 2003 May;6(5):486-90.

Abstract

Novuspharma is developing pixantrone, a second-generation, well-tolerated anthracenedione analog, for the potential treatment of lymphoma and multiple sclerosis.

Publication types

  • Review

MeSH terms

  • Animals
  • Hematologic Neoplasms / drug therapy
  • Humans
  • Isoquinolines / chemistry
  • Isoquinolines / therapeutic use*
  • Technology, Pharmaceutical / legislation & jurisprudence
  • Technology, Pharmaceutical / methods*
  • Technology, Pharmaceutical / trends
  • Topoisomerase II Inhibitors

Substances

  • Isoquinolines
  • Topoisomerase II Inhibitors
  • pixantrone